Google Unveils Native Gemini Application For MacOS As Competition Heats Up

by THEFUTURE.TEAM

April 16, 2026

Seamless Integration With MacOS

Google introduced a native Gemini application for macOS, expanding access to its AI tools on desktop devices and positioning it alongside offerings from OpenAI and Anthropic. The release extends Gemini beyond browser-based use into system-level workflows. Users can access Gemini through a keyboard shortcut (Option + Space), enabling interaction without interrupting ongoing tasks such as writing documents, analyzing data, or working across applications.

Enhanced Interactivity And Real-Time Assistance

Gemini supports screen sharing, including local files, allowing users to request contextual assistance based on on-screen content. Queries can be applied directly to documents, charts, or other materials. For example, users can ask for key takeaways from a chart and receive a structured summary, reducing time spent on manual analysis and supporting faster decision-making.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Advanced Multimedia Capabilities

The application also includes tools for image generation through Nano Banana and video generation through Veo. These features expand Gemini’s functionality beyond text-based use cases. Multi-modal capabilities support a wider range of workflows, including content creation, analysis, and presentation.

Global Availability And Strategic Impact

The macOS application is available globally for devices running macOS 15 and later. Users can download it directly from Google’s official website. This launch expands Gemini’s presence across platforms and strengthens Google’s position in the competitive market for AI productivity tools.

The Future Forbes Realty Global Properties

Colossal Biosciences Seeks Funding At Up To $30 Billion Valuation

by THEFUTURE.TEAM

July 22, 2026

Colossal Biosciences, the biotechnology startup known for its efforts to revive extinct species including the woolly mammoth and dire wolf, is in talks to raise funding at a valuation of $20 billion to $30 billion, according to Axios.

The company was last valued at $10.2 billion in a January funding round. It has since begun generating revenue, Axios reported, although neither the size of the new financing nor its potential investors have been disclosed.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Business Extends Beyond De-Extinction

While Colossal has attracted global attention for its de-extinction projects, the company is also building a broader biotechnology business around the tools developed through that research.

Co-founder and Chief Executive Ben Lamm has said Colossal expects revenue from three areas: conservation technologies, new businesses created from its research and future commercial applications of technologies developed alongside its de-extinction programme.

Expanding Commercial Portfolio

Colossal has already supplied conservation technology to the U.S. government and the United Arab Emirates, which recently invested $60 million in the company, according to Wired.

Its research has also led to the creation of several startups, including plastics recycling company Breaking, computational biology platform Form Bio, which raised $30 million, and AI-driven biology company Astromech, which was valued at $2 billion in March.

Research Continues To Expand

Operating from a 55,000-square-foot facility in Dallas, Colossal continues to broaden its research portfolio.

In April, the company added the bluebuck antelope as its sixth de-extinction target. More recently, the Colossal Foundation partnered with the University of Tasmania to develop vaccines and gene-editing approaches aimed at protecting Tasmanian devils from a contagious facial cancer.

Lamm has also said the company plans to spin out its artificial womb technology, which could eventually have applications in fertility treatment. Speaking to Rolling Stone in May, he said the technology could be ready next year.

Investor Interest In Deep Tech

The fundraising discussions come as investors increase spending on sectors such as biotechnology, longevity and other deep-tech fields.

Lamm has also said Colossal could eventually generate revenue from biodiversity credits if restored species are successfully reintroduced into their natural habitats, creating another potential commercial opportunity.

Breaking news